In Brief: DuPont Merck
Executive Summary
DuPont Merck: Endo Pharmaceuticals created from sale of Endo generics and multi-source business lines to company execs. DuPont Merck President-North America Carol Ammon will head Endo. Firm will receive debt financing from Chase Securities; Kelso & Company and senior execs will provide equity funding. Endo's drug portfolio generated $100 mil. in sales last year; it includes Percocet, Percodan, Hycodan and Hycotuss ("The Pink Sheet" June 16, T&G-4)...
DuPont Merck: Endo Pharmaceuticals created from sale of Endo generics and multi-source business lines to company execs. DuPont Merck President-North America Carol Ammon will head Endo. Firm will receive debt financing from Chase Securities; Kelso & Company and senior execs will provide equity funding. Endo's drug portfolio generated $100 mil. in sales last year; it includes Percocet, Percodan, Hycodan and Hycotuss ("The Pink Sheet" June 16, T&G-4).... |